Inhaled corticosteroid use for asthma is linked to adrenal suppression

被引：1
|
作者：
Lasky-Su, Jessica [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
NATURE MEDICINE | 2022年 / 28卷 / 04期
关键词：
D O I：
10.1038/s41591-022-01732-3
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The largest metabolomic study of asthma thus far, comprising >14,000 people from four independent cohorts, has found that inhaled corticosteroid (ICS) treatment is associated with adrenal suppression, even at low doses. Thus, ICS dosage should be optimized to minimize adrenal suppression while maintaining its established benefits in asthma management.
引用
收藏
页码：645 / 646
页数：2
相关论文
共 50 条
  • [41] Assessment of adrenal suppression in children with asthma treated with inhaled corticosteroids: use of dehydroepiandrosterone sulfate as a screening test
    Dorsey, Morna J.
    Cohen, Laurie E.
    Phipatanakul, Wanda
    Denufrio, Danielle
    Schneider, Lynda C.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 97 (02) : 182 - 186
  • [42] Hypothalamic-pituitary-adrenal axis suppression during inhaled or intranasal corticosteroid treatment
    Prenner, BM
    ADVANCES IN THERAPY, 1996, 13 (03) : 154 - 160
  • [43] Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use
    Ozlem Cavkaytar
    Dogus Vuralli
    Ebru Arik Yilmaz
    Betul Buyuktiryaki
    Ozge Soyer
    Umit M. Sahiner
    Nurgun Kandemir
    Bulent E. Sekerel
    European Journal of Pediatrics, 2015, 174 : 1421 - 1431
  • [44] Evidence of hypothalamic-pituitary-adrenal axis suppression during moderate-to-high-dose inhaled corticosteroid use
    Cavkaytar, Ozlem
    Vuralli, Dogus
    Yilmaz, Ebru Arik
    Buyuktiryaki, Betul
    Soyer, Ozge
    Sahiner, Umit M.
    Kandemir, Nurgun
    Sekerel, Bulent E.
    EUROPEAN JOURNAL OF PEDIATRICS, 2015, 174 (11) : 1421 - 1431
  • [45] Adrenal Suppression with Cushingoid Features from Inhaled Corticosteroid Therapy in an Adult Asthmatic Patient
    Tsoukas, Michael A.
    Krishnamoorthy, Preetha
    Richards, Brent J.
    Pepe, Carmela
    Christopoulos, Stavroula
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (05): : E1 - E2
  • [46] Adrenal Suppression With Chronic Topical Corticosteroid Use in Psoriasis Patients
    Lam, Lisa H.
    Sugarman, Jeffrey L.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (08) : 945 - 948
  • [47] Geographic variation in inhaled corticosteroid use for children with persistent asthma in Medicaid
    Goedken, Amber M.
    Brooks, John M.
    Milavetz, Gary
    Rudzianski, Nicholas J.
    Chrischilles, Elizabeth A.
    JOURNAL OF ASTHMA, 2018, 55 (08) : 851 - 858
  • [48] Adherence to inhaled corticosteroid use and local adverse events in persistent asthma
    Ivanova, J.
    Yu, A. P.
    Birnbaum, H. G.
    Hsieh, M.
    Seal, B.
    Van der Molen, T.
    Emani, S.
    Rosiello, R.
    Colice, G.
    VALUE IN HEALTH, 2008, 11 (03) : A278 - A278
  • [49] Inhaled corticosteroid use and bone-mineral density in patients with asthma
    Wong, CA
    Walsh, LJ
    Smith, CJP
    Wisniewski, AF
    Lewis, SA
    Hubbard, R
    Cawte, S
    Green, DJ
    Pringle, M
    Tattersfield, AE
    LANCET, 2000, 355 (9213): : 1399 - 1403
  • [50] Focus on fluticasone propionate: An inhaled corticosteroid for use in the maintenance treatment of asthma
    Milch, LR
    White, CM
    Wolf, S
    FORMULARY, 1996, 31 (12) : 1165 - &
12345